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Abstract
Objective We report on a patient who developed a meningi-
omamorethantwodecadesafterremovalatayoungageofan
atypical teratoid/rhabdoid tumour (AT/RT), which was due to
a germline INI1 mutation, and radio- and chemotherapy.
Materials and methods We present genetic evidence that
the meningioma is not a recurrence or metastasis of the AT/
RT and not due to the INI1 mutation, but is a radiation-
induced tumour.
Conclusion This is the first case illustrating that improved
survival of young patients with an AT/RT after aggressive
treatment maybegainedatthe costofanincreasedriskfor the
development of radiation-induced, non-INI1-related tumours.
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INI1
Introduction
We previously reported on a family in which four cousins
developed an atypical teratoid/rhabdoid tumour (AT/RT) at
young age, due to inheritance of a germline G>A mutation
in the donor splice site of exon 4 of the tumour suppressor
gene INI1 [2]. More than 20 years after resection of the AT/
RT, the oldest of the four cousins developed an intracranial
meningioma and, after an additional year, a myoepithe-
lioma of the lip. In addition to the constitutional INI1
mutation and loss of the normal INI1 allele, we detected an
identical rearrangement in the NF2 gene, not affecting its
coding regions, in the AT/RT and myoepithelioma of the
patient and concluded that they both originated from a
common precursor cell. However, the rearrangement in
NF2 and loss of the normal INI1 allele could not be
demonstrated in the meningioma. Despite this, the devel-
opment of the meningioma may be the consequence of the
presence of the constitutional INI1 mutation, because
mutations in this gene have been identified in meningiomas
[8]. Alternatively, the meningioma could be induced by the
radiation therapy, which our patient received after removal
of the AT/RT and which is a well-known consequence of
this treatment [1]. We investigated the meningioma for the
presence of genetic changes reported in radiation-induced
meningiomas and performed a comparative loss of hetero-
zygosity (LOH) analysis to demonstrate that such radiation-
induced genetic changes are absent in the AT/RT and
myoepithelioma of our patient.
Materials and methods
Tumour samples and DNA isolation
DNA from the AT/RT and the myoepithelioma was isolated
from formalin-fixed and paraffin-embedded tumour materi-
al, and DNA from the meningioma was isolated from a
fresh frozen tumour sample using commercially available
kits (Qiagen, Venlo, The Netherlands).
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A genome-wide single nucleotide polymorphism (SNP)
analysis of normal and meningioma DNA was conducted
with the Affymetrix GeneChip Human Mapping 10K
Array Xba 142 2.0. The array contains 10,204 SNPs
distributed across the genome. The GeneChips were
p r o c e s s e db ya na u t h o r i s e dA f f y m e t r i xS e r v i c eP r o v i d e r
using standard Affymetrix protocols (Service XS, Leiden,
The Netherlands). LOH regions were identified by
comparing the SNP profiles of normal and meningioma
DNA and scoring heterozygous SNP markers (AB) in the
normal DNA that were reduced to homozygosity (AA or
BB) in the meningioma DNA. Intervals were determined
on the basis of locations of SNP markers in the UCSC
G e n o m eB r o w s e r ,M a r c h2 0 0 6B u i l d ,a thttp://genome.
ucsc.edu/.
LOH analysis
Loss of heterozygosity (LOH) analysis was performed with
microsatellite markers as described previously [3] using
primer sequences and conditions for polymerase chain
reaction given by The Genome Database at http://www.
gdb.org/. Because of rather extensive degradation of DNA
extracted from the AT/RT, only markers generating PCR
fragments smaller than 150 bp were used.
Case report
History
Our patient was diagnosed with a tumour in the fourth
ventricle and right cerebellar hemisphere at the age of
4.5 years. Resection of the tumour was incomplete. The
tumour was originally classified as anaplastic ependymoma
WHO grade III, but upon extensive genetic analysis and
histopathological re-evaluation, reclassified as AT/RT [2]. He
received adjuvant chemotherapy (methotrexate, vincristine
and prednisolone) followed by craniospinal radiotherapy
(3,300 cGy in 22 doses) with a boost of 2,100 cGy on the
location of the tumour. Fifteen years later, a brain CTwithout
contrast showed no signs of recurrent disease or of other new
pathology. Almost 6 years later, 20.5 years after initial
diagnosis, he presented again with bifrontal headaches,
increasing ataxic gait disturbances and fatigue. CT examina-
tion showed a large isodens space-occupying lesion in the
left temporal region with oedema, midline shift and contrast
enhancement. One year after resection of this tumour, he
developed a myoepithelioma of the upper lip. The patient is
alive at 29 years of age.
Histological findings
Histopathological examination of the left temporal tumour
revealed an atypical meningothelial meningioma WHO
grade II with many vessels and up to six mitoses per 2 mm
2.
SNP and LOH analysis Radiation-induced meningiomas
usually display a complex karyotype [1]. To determine the
genetic changes, we performed a genome-wide scan by SNP
analysis of the meningioma and corresponding normal DNA.
The identified chromosomal regions displaying LOH are
listed in Table 1. Next, we tested several markers from
within each of the five largest deleted regions by conven-
Table 1 LOH regions in the meningioma, as determined by SNP
analysis
Chromosome region Exact interval (Mb)
1pter-p34.3 0–38.90
1p33-p33 46.99–51.09
1p32.2-1p31.3 58.19–65.50
2pter-p12 0–79.28
3p26.1-cen 6.11–88.84
7q36.1-qter 150.04–158.66
16pter-p12.1 0–22.75
16q23.1-q23.3 73.46–81.33
17cen-q21.31 23.09–40.35
19pter-p13.2 0–8.83
Fig. 1 LOH analysis using markers from chromosome regions a
1pter-p34.3 (D1S199), b 3p26.1-cen (D3S3727), c 17qcen-q21.31
(D17S1872) and d 22q (D22S430) of AT/RT (A), meningioma (M)
and myoepithelioma (My) DNAs of the patient. N denotes normal
DNA derived from the patient’s blood leucocytes. Arrowhead
indicates position of lost allele
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the meningioma and in the AT/RT and myoepithelioma.
Presence of LOH in the meningioma, but absence of LOH in
AT/RT and myoepithelioma was found for D1S199 in 1pter-
p34.3 (Fig. 1a), D2S327 in 2pter-p12, D3S3727 in 3p26.
1-cen (Fig. 1b), D16S3020 in 16pter-p12.1 and D17S1872 in
17qcen-q21.31 (Fig. 1c). In contrast, as determined previ-
ously [2] and exemplified by marker D22S430 in Fig. 1d,
there was LOH for chromosome 22 markers in the AT/RT
and myoepithelioma, but not in the meningioma.
Discussion
In a previous study, we provided evidence for the involve-
ment of INI1, by constitutional mutation and independent
somatic loss, in the development of both the AT/RT and the
myoepithelioma of our patient. Moreover, we could
demonstrate that these tumours originated from an identical
precursor cell [2]. Although involvement of INI1 has been
described in sporadic meningiomas [8], until now menin-
giomas have not been reported to occur as a consequence of
the inheritance of an INI1 mutation. However, this might be
due to the extreme rarity of families with an inherited INI1
mutation, with only four published cases so far [2, 5, 6, 11].
In this context, it is interesting to note that (as demonstrated
before and exemplified by marker D22S430 in Fig. 1d) the
meningioma of our patient has no LOH 22 and the retained
INI1 allele carries no additional inactivating mutation [2],
indicating that this tumour is not the result of inheritance of
the mutated INI1 gene. In contrast, the meningioma
displayed genetic changes that are characteristic for
radiation-induced meningiomas [1, 7, 9], such as a complex
karyotype, as evidenced by the SNP analysis (Table 1),
including extensive losses on chromosome arm 1p, but no
loss of chromosome 22, and no mutation in the NF2 gene
[2]. The genetic changes found in the meningioma proved
not to be present in the AT/RTor myoepithelioma (Fig. 1a–c,
and data not shown), demonstrating that the meningioma is
genetically not related to these tumours and should not be
considered as a late and more differentiated recurrence or
metastasis of the AT/RT.
In conclusion, the clinical and genetic characteristics of
the meningioma clearly indicate that the tumour developed
as a consequence of the radiation therapy. Recent evidence
suggests that long-term survival of patients with a child-
hood AT/RT can occur especially after aggressive treatment
including radiotherapy [10, 12]. The possible late effects of
radiation therapy have been considered as serious draw-
backs of this treatment. This is the first case in literature in
which such a possible consequence in the form of a
radiation-induced meningioma is actually documented in a
long-term survivor of an AT/RT. Compared to sporadic
meningiomas, radiation-induced meningiomas are more
aggressive and have a higher chance to recur [1]. Because
of this unfavourable prognosis, continuous medical surveil-
lance of our patient is warranted.
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